Dolutegravir/lamivudine/tenofovir
- Wɔatwerɛ nsɛm wei ɛwɔ Asante kasa mu
Dolutegravir(DTG),a Tivicay adwumakuo na wɔtɔn, yɛ aduro a wɔde sa HIV anaa sɛ babasowerɛmfoɔ.Wɔtumi nso de si HIV ano.Wɔde fa anomu.[1]
Yareɛ a Ɛsa
[sesa]Wɔagye dolutegravir ato mu a wɔde yɛ adwuma wɔ nnipa dodoɔ a wɔwɔ HIV. Wɔtumi de sa mpaninfoɔ a wɔwɔ HIV a wɔnyaa HIV ho ayarehwɛ biara.
Nsunsuansoɔ
[sesa]Dolutegravir ho nsunsuansoɔ pa ara ne sɛ wontumi nna ne tipaeɛ.Nsunsuansoɔ nso a ano yɛ den ne brɛboɔ a ɛntumi nni dwuma papa.
Abakɔsɛm
[sesa]Wɔ Ɔgyefoɔ bosome afe 2013 mu no,wɔ U.S nnuane ne nnuro dwumakuo no,wɔde too dwa sɛ dolutegravir ho nyetomu no bɛkyɛ.[2]
Akwanya
[sesa]Wɔ Oforisuo bosome afe 2024 no,Colombia aban gye too mu sɛ dolutegravir na wɔde bɛdi dwuma.
Beaeɛ A Menyaa Mmoa Firiiɛ
[sesa]- ↑ Book sources - Wikipedia (in English), retrieved 2024-08-24
- ↑ "Reuters", Wikipedia (in English), 2024-08-16, retrieved 2024-08-24